Examining Ancestry and Disease in the Age of Genomic Medicine

Sunday, April 30, 2023

11:15 AM – 11:35 AM ET

Location: Convention Center: 206

Speaker(s)

Chris Gignoux, PhD, MS (he/him/his)
Director of Research, Colorado Center for Personalized Medicine, and Associate Professor, Department of Biomedical Informatics
University of Colorado Anschutz Medical Campus

Disclosure(s):

Chris Gignoux: Abbvie (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Bristol Meyers Squibb (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Eli Lilly (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Illumina Inc. (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties); Johnson & Johnson (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Merck (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Pfizer (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)